Stock listing

Pacira Biosciences, Inc.

Selected listing: 82P · BX · CHF · CH

Pacira Biosciences, Inc. (BX Swiss: 82P), Health Technology. Latest release Oct 5, 2026: Pacira Announces Exclusive Agreement with Molteni Farmaceutici…

82P:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: 82P
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

Latest news from Pacira Biosciences, Inc.

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

October 5, 2026

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

October 4, 2026

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

August 6, 2026

Pacira BioSciences Reports Second Quarter 2026 Financial Results

August 4, 2026

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America's Workforce

July 29, 2026

All Pacira Biosciences, Inc. news →

Events

Replays

Pacira BioSciences, Inc. (PCRX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Pacira BioSciences, Inc. (PCRX) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 04:30 PM ET
Watch

Research Pacira Biosciences, Inc.

Pacira Biosciences, Inc. company profile

View the public company page for Pacira Biosciences, Inc. on 6ix.

Pacira Biosciences, Inc. news

Read company news and market updates connected to Pacira Biosciences, Inc..

Pacira Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Pacira Biosciences, Inc..